Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-10-192453
Filing Date
2010-08-19
Accepted
2010-08-18 18:58:00
Documents
6
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d10ka.htm 10-K/A 1668420
2 CERTIFICATION OF JOSEPH K. BELANOFF, M.D. PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 9416
3 CERTIFICATION OF CAROLINE M. LOEWY PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 9278
4 CERTIFICATION OF JOSEPH K. BELANOFF, M.D. PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3747
5 CERTIFICATION OF CAROLINE M. LOEWY PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 3720
6 GRAPHIC g44761g86g03.jpg GRAPHIC 40792
  Complete submission text file 0001193125-10-192453.txt   1752332
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-50679 | Film No.: 101026607
SIC: 2834 Pharmaceutical Preparations